Developer JD Group has scored a partial win in its challenge to a damages award to a Melbourne couple over a “deliberately misleading” rendering of a $9.6 million apartment, with a judge saying the case showed the “inherent risk” in buying apartments off-the-plan.
Vanguard Investments has coughed up almost $40,000 for allegedly misleading investors about funds that purportedly did not invest in companies that sell or manufacture tobacco.
US lingerie and beauty giant Victoria’s Secret has won undertakings from Chemist Warehouse to stop selling allegedly fake fragrance products until a trade mark suit against the pharmacy giant is decided.
Property data analytics firm CoreLogic is taking aim again at a lawsuit accusing it of unauthorised scraping of confidential information from building information provider BCI Media’s copyright-protected leads platform, months after a judge found the case was “defective and deficient”.
Medibank faces a representative proceeding over last month’s data breach that exposed the sensitive information of millions of customers, as the private health insurer reveals more stolen data was posted online overnight.
A judge has cut a funder’s commission by 33 per cent after approving a $20 million settlement in a sham contracting class action against telco contractor BSA Limited, finding that funders should receive “significantly lower” payouts in employment cases.
News outlet Crikey has handed over internal documents showing its plans to mount a marketing campaign portraying itself as the victim in a “David and Goliath” battle with Fox News CEO Lachlan Murdoch over an allegedly defamatory article about the January 6 attack on the US Capitol, a court has heard.
A shareholder class action against a2 Milk has won its bid to include claims under New Zealand law over the dairy company’s disclosures to the New Zealand stock exchange.
A judge has pulled up legal teams in a class action against the state of Victoria on behalf of businesses that allegedly suffered loss from the 2020 hotel quarantine debacle, saying progress in the case has been “extremely slow”.
The competition regulator has detailed “significant” concerns with Cochlear’s proposed acquisition of Oticon Medical, saying Thursday a tie-up would cut to three the number of cochlear implant suppliers in Australia.